Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver-Reference-Cited by-同舟云学术

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

Published:2017-12-27 Issue:4 Volume:283 Page:356-370
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Dongiovanni P.¹,Stender S.²,Pietrelli A.¹³,Mancina R. M.⁴,Cespiati A.¹,Petta S.⁵,Pelusi S.¹,Pingitore P.⁴,Badiali S.⁶,Maggioni M.⁷,Mannisto V.⁸,Grimaudo S.⁵,Pipitone R. M.⁵,Pihlajamaki J.⁹¹⁰¹¹,Craxi A.⁵,Taube M.¹¹,Carlsson L. M.S.¹²,Fargion S.¹¹³,Romeo S.⁴¹⁴¹⁵,Kozlitina J.¹⁶,Valenti L.¹¹³^ORCID

Affiliation:

1. Internal Medicine and Metabolic Diseases; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan Italy

2. Department of Molecular Genetics; University of Texas Southwestern Medical Center; Dallas TX USA

3. Bioinformatic unit; Istituto Nazionale Genetica Molecolare; Milan Italy

4. Department of Molecular and Clinical Medicine; University of Gothenburg; Gothenburg Sweden

5. Department of Gastroenterology; Università di Palermo; Palermo Italy

6. Department of Surgery; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan Italy

7. Department of Pathology; Fondazione IRCCS Ca' Granda Ospedale Policlinico Milano; Milan Italy

8. Department of Gastroenterology; University of Eastern Finland; Kuopio University Hospital; Kuopio Finland

9. Department of Medicine; University of Eastern Finland; Kuopio University Hospital; Kuopio Finland

10. Clinical Nutrition and Obesity Center; Kuopio University Hospital; Kuopio Finland

11. Department of Public Health and Clinical Nutrition; University of Eastern Finland; Kuopio Finland

12. Institute of Medicine; Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

13. Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan Italy

14. Clinical Nutrition Unit; Department of Medical and Surgical Sciences; University Magna Graecia; Catanzaro Italy

15. Cardiology Department; Sahlgrenska University Hospital; Gothenburg Sweden

16. McDermott Center for Human Growth and Development; University of Texas Southwestern Medical Center; Dallas TX USA

Funder

Associazione Italiana per la Ricerca sul Cancro

Molecular Medicine Grant Fondazione IRCCS Ca' Granda and INGM 2014

Ricerca Corrente Fondazione Ca' Granda IRCCS Policlinico of Milan

Associazione Malattie Metaboliche del Fegato ONLUS

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

Svenska Forskningsrådet Formas

Hjärt-Lungfonden

Swedish federal government funding under the Agreement on Medical Training and Medical Research

Sahlgrenska Universitetssjukhuset

Novo Nordisk

Swedish Diabetes Foundation

Stiftelserna Wilhelm och Martina Lundgrens

Kungliga Fysiografiska Sällskapet i Lund

Sundhed og Sygdom, Det Frie Forskningsråd

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12719/fullpdf

Reference45 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

2. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups;Lonardo;Dig Liver Dis,2015

3. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?;Valenti;Liver Int,2016

4. Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team;Dyson;J Hepatol,2014

5. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Triadica cochinchinensis honey supplementation on liver metabolomics and gut microbiota in naturally aging mice;Food Bioscience;2024-10

2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

3. Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial;Diseases;2024-08-17

4. Clinical value of γ-glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study;Heliyon;2024-08

5. Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response;Stem Cells and Development;2024-08-01